GRI GRI Bio, Inc.
Fundamentals / CIK 0001824293 / USDGRI Bio, Inc. reported $9.76M in total assets and a net loss of $7.81M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GRI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$7.83M Operating profit
-
Net Income FY 2025-$7.81M GAAP bottom line
-
Diluted EPS FY 2025-$3.57 Split-adjusted
-
Free Cash Flow FY 2025-$10.19M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$9.47M Total debt: $30K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $0 | $100K |
| Research & Development | $6.82M | $3.77M | $3.23M | $242K | $5.19M | $3.71M |
| Total Operating Expenses | $11.98M | $8.23M | $11.39M | $2.24M | $9.26M | $4.89M |
| Operating Income | -$11.98M | -$8.23M | -$11.39M | -$2.24M | -$9.26M | -$4.79M |
| EBITDA | -$11.97M | -$8.23M | -$11.38M | -$2.24M | -- | -- |
| Income Tax Expense | $3.0K | $2.0K | -- | -- | -- | -- |
| Net Income | -$11.96M | -$8.21M | -$13.04M | -$3.22M | -$9.30M | -$4.82M |
| Basic EPS | -$121.80 | -$1,545.55 | -$6,693,487,957.60 | -$160,854,335,804,675,328.00 | -$274,919,998,366,268,864.00 | -$207,158,026,937,963,200.00 |
| Diluted EPS | -$121.80 | -$1,545.55 | -$6,693,487,957.60 | -$160,854,335,804,675,328.00 | -$274,919,998,366,268,864.00 | -$207,158,026,937,963,200.00 |
| Basic Shares Outstanding | 98.2K | 6.5K | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 98.2K | 6.5K | 0 | 0 | 0 | 0 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $212K | $407K | $361K | $1.63M | $1.77M | $1.88M | $1.64M | $907K |
| Total Operating Expenses | $1.51M | $1.65M | $2.00M | $2.66M | $3.37M | $2.90M | $3.05M | $1.95M |
| Operating Income | -$1.51M | -$1.65M | -$2.00M | -$2.66M | -$3.37M | -$2.90M | -$3.05M | -$1.95M |
| EBITDA | -$1.51M | -$1.65M | -$2.00M | -$2.66M | -$3.36M | -$2.90M | -$3.05M | -$1.95M |
| Net Income | -$1.51M | -$1.64M | -$2.00M | -$2.66M | -$3.36M | -$2.89M | -$3.05M | -$1.95M |
| Basic EPS | -$0.69 | -$0.91 | -$1.61 | -- | -$35.88 | -$36.72 | -$162.30 | -- |
| Diluted EPS | -$0.69 | -$0.91 | -$1.61 | -- | -$35.88 | -$36.72 | -$162.30 | -- |
| Basic Shares Outstanding | 2.2M | 1.8M | 1.2M | -- | 93.6K | 78.8K | 18.8K | -- |
| Diluted Shares Outstanding | 2.2M | 1.8M | 1.2M | -- | 93.6K | 78.8K | 18.8K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.23M | $5.03M | $1.81M | $9.0K | $3.70M | $109K |
| Short-Term Investments | -- | -- | -- | $0 | $3.81M | $0 |
| Cash & Short-Term Investments | $8.23M | $5.03M | $1.81M | $9.0K | $7.51M | $109K |
| Total Current Assets | $8.59M | $5.62M | $2.93M | $312K | $8.13M | $674K |
| Property, Plant & Equipment, Net | $3.0K | $4.0K | $8.0K | $4.0K | $0 | $2.0K |
| Other Non-Current Assets | -- | -- | -- | $0 | $206K | $279K |
| Total Non-Current Assets | $74K | $124K | $22K | $71K | $206K | $281K |
| Total Assets | $8.67M | $5.74M | $2.96M | $383K | $8.34M | $955K |
| Accounts Payable | $1.84M | $897K | $1.41M | $1.29M | $918K | $1.23M |
| Other Current Liabilities | -- | -- | -- | $0 | $97K | $105K |
| Total Current Liabilities | $2.64M | $1.64M | $2.70M | $1.99M | $2.44M | $2.23M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $72K | $170K |
| Total Non-Current Liabilities | $15K | $71K | $0 | $14K | $72K | $184K |
| Total Liabilities | $2.66M | $1.71M | $2.70M | $2.01M | $2.52M | $2.41M |
| Total Debt (incl. Leases) | $71K | $119K | $14K | $71K | $169K | $275K |
| Retained Earnings | -$51.70M | -$39.74M | -$31.53M | -$18.50M | -$21.90M | -$12.60M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | -$2.0K | $0 |
| Total Stockholders' Equity | $6.01M | $4.03M | $259K | -$1.62M | -$4.85M | -$1.45M |
| Total Equity | $6.01M | $4.03M | $259K | -$1.62M | -$4.85M | -$1.45M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $9.47M | $10.95M | $11.05M | $8.23M | $4.05M | $5.12M | $3.28M | $5.03M |
| Cash & Short-Term Investments | $9.47M | $10.95M | $11.05M | $8.23M | $4.05M | $5.12M | $3.28M | $5.03M |
| Total Current Assets | $9.73M | $11.33M | $11.28M | $8.59M | $4.70M | $5.58M | $3.93M | $5.62M |
| Property, Plant & Equipment, Net | $2.0K | $2.0K | $2.0K | $3.0K | $1.0K | $2.0K | $3.0K | $4.0K |
| Total Non-Current Assets | $32K | $46K | $60K | $74K | $85K | $99K | $112K | $124K |
| Total Assets | $9.76M | $11.38M | $11.34M | $8.67M | $4.78M | $5.67M | $4.04M | $5.74M |
| Accounts Payable | $354K | $526K | $303K | $1.84M | $1.32M | $1.30M | $1.36M | $897K |
| Total Current Liabilities | $953K | $1.10M | $794K | $2.64M | $2.76M | $2.31M | $2.78M | $1.64M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $15K | $30K | $44K | $58K | $71K |
| Total Liabilities | $953K | $1.10M | $794K | $2.66M | $2.79M | $2.35M | $2.84M | $1.71M |
| Total Debt (incl. Leases) | $30K | $44K | $58K | $71K | $84K | $96K | $108K | $119K |
| Retained Earnings | -$56.84M | -$55.34M | -$53.69M | -$51.70M | -$49.04M | -$45.68M | -$42.79M | -$39.74M |
| Total Stockholders' Equity | $8.81M | $10.28M | $10.54M | $6.01M | $1.99M | $3.32M | $1.21M | $4.03M |
| Total Equity | $8.81M | $10.28M | $10.54M | $6.01M | $1.99M | $3.32M | $1.21M | $4.03M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$11.96M | -$8.21M | -$13.04M | -$3.22M | -$9.30M | -$4.82M |
| Depreciation & Amortization | $4.0K | $4.0K | $4.0K | $3.0K | -- | -- |
| Stock-Based Compensation | $793K | $148K | $388K | $25K | $626K | $154K |
| Change in Payables | $663K | -$387K | $2.16M | $897K | -$308K | $980K |
| Operating Cash Flow | -$10.19M | -$8.61M | -$8.99M | -$1.08M | -$8.31M | -$3.71M |
| Capital Expenditure | -$3.0K | $0 | -$8.0K | -$3.0K | $0 | -$2.0K |
| Free Cash Flow | -$10.19M | -$8.61M | -$9.00M | -$1.09M | -$8.31M | -$3.71M |
| Purchases of Investments | -- | -- | -- | -$640K | -$3.84M | $0 |
| Investing Cash Flow | -$3.0K | $0 | -$8.0K | -$3.0K | -$3.84M | -$2.0K |
| Common Stock Issued | -- | -- | $12.25M | $0 | -- | -- |
| Financing Cash Flow | $13.39M | $11.83M | $10.80M | $1.01M | $15.75M | -$4.0K |
| Net Change in Cash | $3.20M | $3.22M | $1.80M | -$81K | $3.59M | -$3.71M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.51M | -$1.64M | -$2.00M | -$2.66M | -$3.36M | -$2.89M | -$3.05M | -$1.95M |
| Depreciation & Amortization | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Stock-Based Compensation | $32K | $33K | $31K | $67K | $465K | $41K | $220K | $37K |
| Change in Payables | -$172K | $223K | -$1.51M | $272K | $20K | $40K | $331K | -$240K |
| Operating Cash Flow | -$1.48M | -$1.45M | -$3.69M | -$2.97M | -$2.31M | -$3.17M | -$1.74M | -$2.00M |
| Common Stock Issued | -- | -- | $6.82M | -- | -- | -- | $0 | -- |
| Financing Cash Flow | $0 | $1.34M | $6.50M | $7.15M | $1.25M | $5.01M | -$11K | $2.28M |
| Net Change in Cash | -$1.48M | -$101K | $2.82M | $4.17M | -$1.07M | $1.84M | -$1.75M | $282K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -4788.0% |
| Net Profit Margin | -- | -- | -- | -- | -- | -4822.0% |
| Return on Equity (ROE) | -199.0% | -203.5% | -5033.6% | -- | -- | -- |
| Return on Assets (ROA) | -138.0% | -143.0% | -441.0% | -839.9% | -111.6% | -504.9% |
| Current Ratio | 3.25x | 3.43x | 1.09x | 0.16x | 3.32x | 0.30x |
| Quick Ratio | 3.11x | 3.07x | 0.67x | 0.00x | 3.07x | 0.05x |
| Debt to Equity | 0.01x | 0.03x | 0.05x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -- | -- | -- | -100.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -88.6% | -94.0% | -103.4% | -199.0% | -564.2% | -301.3% | -777.3% | -203.6% |
| Return on Assets (ROA) | -80.0% | -84.9% | -96.2% | -138.0% | -235.2% | -176.4% | -231.7% | -143.0% |
| Current Ratio | 10.21x | 10.30x | 14.21x | 3.25x | 1.70x | 2.41x | 1.41x | 3.43x |
| Quick Ratio | 9.94x | 9.95x | 13.91x | 3.11x | 1.47x | 2.22x | 1.18x | 3.07x |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.04x | 0.03x | 0.09x | 0.03x |